Notification of availability of fibroblasts for Parkinson’s Disease Research:
NINDS is creating a fibroblast resource for Parkinson’s Disease Research which will be available through the NINDS repository at Coriell. The first fibroblast line available for distribution carries a synuclein triplication mutation. Additional fibroblast lines carrying autosomal recessive and dominant mutations associated with Parkinson’s Disease, as well as fibroblasts from idiopathic Parkinson’s Disease cases and age-matched control subjects will be available through the NINDS repository over the next 18 month period.
Point of Contact: Margaret Sutherland, Ph.D., Program Director
Last updated October 25, 2013